The State Food and Drug Administration held a symposium on promoting the comprehensive revitalization of Northeast China, implemented the implementation plan of the 14th five year plan for the comprehensive revitalization of Northeast China and several measures of the State Food and drug administration to support the comprehensive revitalization of Northeast China, and deployed to promote the comprehensive revitalization of Northeast China. The meeting stressed the need to support the inheritance, innovation and development of traditional Chinese medicine, build a genuine brand of northeast medicinal materials, and strengthen the quality and safety supervision of traditional Chinese medicine.
Since 2016, the state has paid more attention to traditional Chinese medicine. It has successively promulgated the outline of traditional Chinese medicine development strategy (2016-2030) and the law of the people’s Republic of China on traditional Chinese medicine. Since then, it has successively issued a number of relevant policies, and the top-level design has been gradually improved. In 2021, the state has important policies on drugs, medical units and medical insurance. In terms of drugs, such as several policies and measures to accelerate the development of characteristics of traditional Chinese medicine, support the innovation of traditional Chinese medicine varieties. From 2016 to 2020, only 2-3 traditional Chinese medicines were approved each year, and the number of approved drugs remained low for a long time. However, a total of 12 innovative traditional Chinese medicines were approved in 2021, reaching a new high.
According to the theme database of financial Associated Press, among the relevant listed companies:
Jilin Zixin Pharmaceutical Industrial Co.Ltd(002118) is located in the hinterland of Changbai Mountain Tourism Co.Ltd(603099) . There are more than 1400 kinds of medicinal materials of Changbai Mountain Tourism Co.Ltd(603099) origin, which makes the company have obvious advantages in raw material resources. The company also plants traditional Chinese medicine in Dunhua caohuandan base and Liuhe Hongshi base.
Xiaojin pill, the leading product of Yongkang pharmaceutical, a wholly-owned subsidiary of Tonghua Golden-Horse Pharmaceutical Industey Co.Ltd(000766) , won the bid for centralized volume procurement of inter provincial alliance of Chinese patent medicine.
